Tailored psychotherapy for patients with functional neurological symptoms: A pilot study

Journal of Psychosomatic Research

Volumn 63, Issue 6, 2007, Pages 625-632

  Reuber, Markus ^a   Burness, Christine ^b   Howlett, Stephanie ^b   Brazier, John ^c   Grünewald, Richard ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Dissociative disorder; Functional symptoms; Neurology; Nonepileptic seizures; Psychotherapy; Somatoform disorder

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL OUTCOMES IN ROUTINE EVALUATION OUTCOME MEASURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISSOCIATIVE DISORDER; EMOTION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT HEALTH QUESTIONNAIRE 15; PILOT STUDY; PSYCHOTHERAPIST; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEIZURE; SHORT FORM 36; SOMATOFORM DISORDER; TREATMENT OUTCOME; VALIDATION PROCESS; WELLBEING;

ADULT; AFFECT; AGED; COGNITION DISORDERS; COST-BENEFIT ANALYSIS; DISSOCIATIVE DISORDERS; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GAIT DISORDERS, NEUROLOGIC; HEALTH STATUS; HUMANS; INTENTION; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHOTHERAPY; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 36549085542     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2007.06.013     Document Type: Article

References (48)

1. Carson A., Ringbauer B., Stone J., McKenzie L., and Warlow C. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatients. J Neurol Neurosurg Psychiatry 68 (2000) 207-210
2. Carson A., Ringbauer B., MacKenzie L., Warlow C., and Sharpe M. Neurological disease, emotional disorder, and disability: they are related. A study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry 68 (2000) 202-206
3. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines (1992), WHO, Geneva
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (1994), APA, Washington, DC
5. Reuber M., Mitchell A., Howlett S., Crimlisk C., and Grünewald R. Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry 76 (2005) 307-314
6. Fink P., Sorensen L., Engberg M., Holm M., and Munk-Jorgensen P. Somatization in primary care-prevalence, health care utilization and general practitioner recognition. Psychosomatics 40 (1999) 331-338
7. Kroenke K., Spitzer R., Williams J., Linzer M., Hahn S., deGruy F., and Brody D. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 3 (1994) 774-779
8. Stone J. Functional weakness. PhD Thesis, University of Edinburgh 2006.
9. Binzer M., Stone J., and Sharpe M. Recent onset pseudoseizures-clues to aetiology. Seizure 13 (2004) 146-155
10. Reuber M, Howlett S, Khan A, Grünewald R. Nonepileptic seizures and other functional neurological symptoms: predisposing, precipitating and perpetuating factors. Psychosomatics 2007;48:230-8.
11. Carson A., Best S., Warlow C., and Sharpe M. Suicidal ideation among outpatients at general neurology clinics: an outpatient study. Br Med J 320 (2000) 1311-1312
12. Reid S., Wessely S., Crayford T., and Hotopf M. Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. Br J Psychiatry 180 (2002) 248-253
13. LaFrance W., and Barry J. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav 7 (2005) 364-374
14. Reuber M., Howlett S., and Kemp S. Psychologic treatment for patients with psychogenic nonepileptic seizures. Exp Op Neurotherapeut 5 (2005) 737-752
15. Sharpe M., Peveler R., and Mayou R. The psychological treatment of patients with functional somatic symptoms: a practical guide. J Psychosom Res 36 (1992) 515-529
16. Looper K., and Kirmayer L. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 70 (2002) 810-827
17. Brown R. Medically unexplained symptoms. In: Tarrier N. (Ed). Case formulation in cognitive behaviour therapy (2006), Routledge, London 263-292
18. Parry G. NHS psychotherapy services in England-review of strategic policy (1996), Crown Copyright, London
19. Howlett S, Grünewald R, Khan A, Reuber M. Engagement in psychological treatment for functional neurological symptoms-barriers and solutions. Psychotherapy Theory, Research, Practice, Training [In press].
20. Kishore G., Blair A., Scholes K., and Reuber M. Outcome of a referral for psychotherapy of patients with functional neurological symptoms or psychiatric disorders presenting to a neurologist. J Neurol Neurosurg Psychiatry 76 (2005) 1321
21. Hobson R. Forms of feeling (1985), Tavistock, London
22. Shapiro D., and Firth J. Prescriptive v. exploratory psychotherapy. Outcomes of the Sheffield Psychotherapy Project. Br J Psychiatry 151 (1987) 790-799
23. Creed F., Fernandes L., Guthrie E., Palmer S., Ratcliffe J., Read N., Rigby C., Thompson D., and Tomeson B. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124 (2003) 303-317
24. Guthrie E., Creed F., Dawson D., and Tomeson B. A controlled trial of psychological treatment for irritable bowel syndrome. Gastroenterology 100 (1991) 450-457
25. Cahill J., Barkham M., Stiles W., Twigg E., Hardy G., Rees A., and Evans C. Convergent validity of the CORE measures with measures of depression for clients in cognitive therapy for depression. J Couns Psychol 53 (2006) 253-259
26. Leach C., Lucock M., Barkham M., Stiles W., Noble R., and Iveson S. Transforming between Beck Depression Inventory and CORE-OM scores in routine clinical practice. Br J Clin Psychol 45 (2006) 153-166
27. Ware J., Kosinski M., and Gandek B. SF36 (R) Health Survey manual and interpretation guide (2000), Qualimetric Incorporated, Lincoln (RI)
28. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 (2002) 271-292
29. Spitzer R., Williams J., Kroenke K., Linzer M., deGruy F., Hahn S., Brody D., and Johnson J. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. J Am Med Assoc 272 (1994) 1749-1756
30. Kroenke K., Spitzer R., and Williams J. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64 (2002) 258-266
31. Baker G., Brooks J., Goodfellow L., Bodde N., and Aldenkamp A. Treatments for non-epileptic attack disorder. Cochrane Database Syst Rev 24 (2007) CD006370
32. Kroenke K., and Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 69 (2000) 205-215
33. Roth A., and Fonagy P. What works for whom? A critical review of psychotherapy research (2005), The Guilford Press, New York
34. Barsky A., and Ahern D. Cognitive behavior therapy for hypochondriasis. J Am Med Assoc 291 (2004) 1464-1470
35. National Institute of Clinical Excellence. Post-traumatic stress disorder (PTSD)-the management of PTSD in adults and children in primary and secondary care (2005), National Institute of Clinical Excellence, London
36. Wildgoose A., Clarke S., and Waller G. Treatment of personality fragmentation and dissociation in borderline personality disorder: a pilot study of the impact of cognitive analytical therapy. Br J Med Psychol 74 (2001) 47-55
37. McMain S., Korman L., and Dirneff L. Dialectical behavior therapy and the treatment of emotion dysregulation. J Clin Psychol 57 (2001) 183-196
38. O'Malley P., Jackson J., Santoro J., Tomkins G., Balden E., and Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 48 (1999) 980-990
39. Stone J., Sharpe M., Rothwell P., and Warlow C. The 12-year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 74 (2003) 591-596
40. Reuber M., Pukrop R., Bauer J., Helmstaedter C., Tessendorf N., and Elger C. Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol 53 (2003) 305-311
41. Crimlisk H., Bhatia K., Cope H., David A., Marsden C., and Ron M. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. Br Med J 316 (1998) 582-586
42. Rawlins M., and Culyer A. National Institute for Clinical Excellence and its value judgments. Br Med J 329 (2004) 224-227
43. Wilby J., Kainth A., Hawkins N., Epstein D., McIntosh H., McDaid C., Mason A., Golder S., O'Meara S., Sculpher M., Drummond M., and Forbes C. Clinical effectiveness, tolerability and cost-effectiveness of newer antiepileptic drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 9 (2005) 1-157
44. Chilcott J., McCabe C., Tappenden P., O'Hagan A., Cooper N., Abrams K., Claxton K., and Miller D. Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: Evaluating disease modifying treatments in multiple sclerosis. Br Med J 326 (2003) 522
45. Juarez-Garcia A., Stokes T., Shaw B., Camosso-Stefinovic J., and Baker R. The costs of epilepsy misdiagnosis in England and Wales. Seizure 15 (2006) 598-605
46. Smith G., Rost K., and Kashner T. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Arch Gen Psychiatry 52 (1995) 238-243
47. Bleichhardt G., Timmer B., and Rief W. Cognitive-behavioural therapy for patients with multiple somatoform symptoms: a randomized controlled trial in tertiary care. J Psychosom Res 56 (2004) 449-454
48. Pinson L, Gray GE. Psychopharmacology: number needed to treat: an underused measure of treatment effect. Psychiatr Serv 2003;54:145-6, 154.